FDA approves first medical device to treat ADHD in children

National

TAMPA (WFLA/CNN) — A medical device to treat childhood ADHD has been approved by the FDA. 

The Monarch external Trigeminal Nerve Stimulation System was given the ok by the U.S Food and Drug Administration on Friday. 

It’s designated for children ages seven to 12 who are not currently on medication for the disorder and to be worn while a child is sleeping and it’s the first medical device of its kind. 

A small adhesive patch is placed on the child’s forehead and delivers a low-level electrical pulse to the parts of the brain responsible for ADHD symptoms.

The device has also been investigated as a possible treatment for traumatic brain injury in veterans.

According to the NeuroSigma website, the device is not currently covered by insurance and could cost just over $1,000 for the starter kit.

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

LKQD Outstream

Don't Miss

Nativo

WAVY Twitter Widget

WAVY Facebook